21 CFR 522.1610
§ 522.1610 Oleate sodium.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 522.1610, § 522.1610 Oleate sodium, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87494
- Permanent ID
ys:prov:87494@1- SHA-256
21c31c446cf8cf5ed20a7b66495df28fb94828db2ac03b0066c746e9ce9de391
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of solution contains 50 milligrams (mg) of sodium oleate.
(b) Sponsor. See No. 037990 in § 510.600(c) of this chapter.
(c) Conditions of use in horses—(1) Amount. Administer by parenteral injection depending on the area of response desired. An injection of 1 milliliter (mL) will produce a response of approximately 15 square centimeters. Do not inject more than 2 mL per injection site. Regardless of the number of injection sites, the total volume used should not exceed 10 mL.
(2) Indications for use. It is used in horses to stimulate infiltration of cellular blood components that subsequently differentiate into fibrous and/or fibrocartilagenous tissue.
(3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.